AstraZeneca and Pangaea partner for AI detection of hypophosphatasia
AstraZeneca’s unit Alexion has partnered with Pangaea Data to fund the startup’s development of an AI tool for detecting HPP. The post AstraZeneca and Pangaea partner for AI detection of hypophosphatasia appeared first on Medical Device Network.

The post AstraZeneca and Pangaea partner for AI detection of hypophosphatasia appeared first on Medical Device Network.